Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c.
Ontology highlight
ABSTRACT: Because there are currently no biological treatments for hearing loss, we sought to advance gene therapy approaches to treat genetic deafness. We focused on Usher syndrome, a devastating genetic disorder that causes blindness, balance disorders and profound deafness, and studied a knock-in mouse model, Ush1c c.216G>A, for Usher syndrome type IC (USH1C). As restoration of complex auditory and balance function is likely to require gene delivery systems that target auditory and vestibular sensory cells with high efficiency, we delivered wild-type Ush1c into the inner ear of Ush1c c.216G>A mice using a synthetic adeno-associated viral vector, Anc80L65, shown to transduce 80-90% of sensory hair cells. We demonstrate recovery of gene and protein expression, restoration of sensory cell function,
SUBMITTER: Pan B
PROVIDER: S-EPMC5340578 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA